Buscar
Mostrando ítems 21-30 de 151
CYCLIC AMP INHIBITS TGF
(Wiley-Liss, Inc., 2003-07-04)
Mouse-transformed keratinocytes cultured in the presence
of transforming growth factor 1 (TGF- 1) acquire an array
of morphologic and functional properties that give rise to a
migratory phenotype that expresses mesenchymal ...
EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases
(Elsevier Inc., 2004)
Urokinase-type plasminogen activator receptor (uPAR) and epidermal growth factor receptor (EGFR) are ubiquitous receptors involved in
the control of a variety of cellular processes frequently found altered in cancer cells. ...
EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases
(ACADEMIC PRESS INC ELSEVIER SCIENCE, 2004-01-01)
Urokinase-type plasminogen activator receptor (uPAR) and epidermal growth factor receptor (EGFR) are ubiquitous receptors involved in the control of a variety of cellular processes frequently found altered in cancer cells. ...
Multiparity upregulates placental plasminogen and urokinase-type plasminogen activator
(Wiley Blackwell Publishing, Inc, 2017-04)
Problem: Multiparity increased the number of trophoblast cells in decidua of both low and high fetal loss mouse models. However, they differ in fetal survival rate and maternal thymocyte subpopulations, suggesting that ...
Reversal of hepatic cirrhosis with urokinase-plasminogen activator gene therapy.
(W B SAUNDERS CO, 2000)
Reversal of hepatic cirrhosis with urokinase-plasminogen activator gene therapy.
(W B SAUNDERS CO, 2000)